News

December 12, 2017December 12, 2017

Kalydeco Seen As Safe in Treating CF in Young Children, Ages 1 to 2, Study Data Show

Cystic Fibrosis, News

Kalydeco (ivacaftor) was shown to be safe and well-tolerated in 1- and 2-year-old children with cystic fibrosis (CF), based on data from a Phase 3 trial, Vertex Pharmaceuticals announced. Additionally, trial ... Read more

December 11, 2017December 11, 2017

Tecentriq Adds 38% to the Time It Takes for Lung Cancer to Progress, Trial Shows

Lung Cancer, News

Adding Genentech’s Tecentriq (atezolizumab) to a combination of Avastin and chemotherapy led to lung cancer patients living 38 percent longer before their disease progressed or they died, a Phase 3 trial shows. The ... Read more

December 8, 2017December 8, 2017

Inhaled Thyroid Hormone May Work to Reverse Lung Fibrosis, Early Study Reports

Idiopathic Pulmonary Fibrosis, News

A study led by researchers at Yale School of Medicine showed that an inhalation treatment based on thyroid hormone can significantly reverse lung scarring (fibrosis) in mice models of pulmonary fibrosis and ... Read more

December 7, 2017December 7, 2017

Link Between Testosterone and Asthma Seen in Study, Likely Reason Women More Prone to This Disease

Asthma, News

Testosterone levels control the numbers of a rare subset of white blood cells that are involved in airway inflammation and asthma, a study reports. The finding helps to explain previously ... Read more

December 6, 2017December 12, 2017

Former Football Player Helping CF Patients Obtain AffloVest Airway-clearing Devices

Cystic Fibrosis, News

A former American football player’s foundation is teaming up with AffloVest to provide one of the company’s airway-clearing devices to a cystic fibrosis patient in each of the 50 states. The partners are ... Read more

December 5, 2017December 5, 2017

Veracyte Says Study Backs Up Usefulness of Envisia Genomic Classifier as IPF Diagnostic Tool

Idiopathic Pulmonary Fibrosis, News

Veracyte says new data confirming the analytical validity of its Envisia Genomic Classifier demonstrate its benefits in diagnosing idiopathic pulmonary fibrosis (IPF). The study, “Analytical performance of Envisia: a genomic classifier for ... Read more

December 4, 2017December 4, 2017

FDA Advisory Group Sets Jan. 11 Review Date for Linhaliq, Potential Non-CF Bronchiectasis Therapy

Bronchiectasis, News

A committee of the U.S. Food and Drug Administration (FDA) will meet next month to review an application for Linhaliq to be approved for the treatment of patients with non-cystic fibrosis bronchiectasis ... Read more

December 1, 2017December 1, 2017

Restoring a DNA Repair Protein Reverses Lung Scarring, Mouse Study in Germany Shows

Idiopathic Pulmonary Fibrosis, News

Restoring a DNA repair protein that is missing in pulmonary fibrosis reversed the lung scarring that is the hallmark of the disease, a German study in mice has shown. The ... Read more

November 30, 2017November 30, 2017

Skin Disease Atopic Dermatitis and Susceptibility to Allergies Increase Risk of Asthma, Study Finds

Asthma, News

Year-old infants who have a skin disease known as atopic dermatitis, and who are prone to allergies, are seven times more likely to develop asthma., a Canadian study finds. They ... Read more

November 29, 2017November 29, 2017

Boston and Toronto Researchers Discover Two Additional Molecules Involved in Lung Scarring

Idiopathic Pulmonary Fibrosis, News

Researchers in Boston and Toronto have discovered another molecular mechanism involved in lung scarring. The team at Massachusetts General Hospital and Toronto’s University Health Network said scientists might be able to develop a ... Read more